Few prospective studies, and none in Asians, have systematically evaluated the relationship between blood metabolites and colorectal cancer risk. We conducted a nested case-control study to search for risk-associated metabolite biomarkers for colorectal cancer in an Asian population using blood samples collected prior to cancer diagnosis. Conditional logistic regression was performed to assess associations of metabolites with cancer risk. In this study, we included 250 incident cases with colorectal cancer and individually matched controls nested within two prospective Shanghai cohorts. We found 35 metabolites associated with risk of colorectal cancer after adjusting for multiple comparisons. Among them, 12 metabolites were glycerophospholipids including nine associated with reduced risk of colorectal cancer and three with increased risk [odds ratios per standard deviation increase of transformed metabolites: 0.31-1.98; p values: 0.002-1.25 3 10
Colorectal cancer is the most commonly diagnosed malignancy of the digestive system with 1.3 million new patients diagnosed annually worldwide. 1 Multiple risk factors of colorectal cancer-including obesity, type 2 diabetes, cigarette smoking and heavy alcohol consumption [2] [3] [4] -are related to metabolic perturbation. 5 It has been recognized that alteration of energy metabolism and metabolic reprogramming are critical for tumor initiation and progression. 6, 7 A systematic evaluation of metabolomic profiles prior to cancer diagnosis can help facilitate the discovery of biomarkers for early detection of cancer and improve the understanding of cancer etiology and biology.
Most metabolomics studies conducted to date for colorectal cancer are retrospective, 8, 9 and thus results from these studies could be affected by prevalent biases due to the presence of cancer or changes of lifestyles after cancer diagnosis. A prospective study conducted in Caucasians investigated blood metabolites in relation to risk of colorectal cancer and identified a suggestive inverse association of leucyl-leucine. 10 However, no statistically significant association was found after adjusting for multiple comparisons. 10 Herein, we report results from a metabolomics study conducted in Chinese to systematically search novel blood biomarkers for colorectal cancer risk using samples collected prior to cancer diagnosis.
Materials and Methods

Study population
This case-control study was nested within two populationbased prospective cohorts, the Shanghai Women's Health Study (SWHS) and the Shanghai Men's Health Study (SMHS). Detailed methodology for these two cohort studies was described in previous publications. 11, 12 Briefly, 74,941
women aged 40-70 years were recruited for the SWHS from 1996 to 2000, and 61,480 men aged 40-74 years were recruited for the SMHS from 2002 to 2006 from urban Shanghai, China. In-person interviews were conducted at baseline to collect information on socio-demographics, disease history and medication use, family history of cancer, dietary intakes, cigarette smoking, alcohol consumption and other lifestyle factors. Participants' height, weight and waist and hip circumferences were measured following a standard protocol. At the time of the baseline survey, a 10 mL blood sample was collected and placed in an EDTA tube. Blood samples were kept at 48C during transportation and processed within 6 hr. Plasma was aliquoted to 2 mL vials for long-term storage at 2758C until needed for analysis. All participants are followed by a combination of annual linkage with the population-based Shanghai Tumor Registry and Vital Statistics Registry and in-person surveys taking place every 2-4 years. Incident cancer cases are verified via reviews of medical charts. Institutional review boards of all involved institutes approved the studies, and written informed consent was obtained from all participants prior to interview. For this study, we selected cases and controls from cohort members who provided blood samples at baseline, accounting for 75% of each cohort. In this study, we included 250 incident colorectal cancers (125 women; 125 men) randomly selected from the 1,855 incident cases diagnosed before 2013. A control was randomly selected from the risk set of cancerfree cohort members for each index case using the incidence density sampling method and matched to the case on age (62 years), sex, date of sample collection (630 days), time of sample collection (morning or afternoon), time interval after last meal (62 hr), recent antibiotic use (yes or no) and menopausal status (for women).
Global metabolic profiling of plasma samples by GC-TOFMS
Metabolites in the plasma were derivatized and subsequently analyzed by gas chromatography time-of-flight mass spectrometry (GC-TOFMS) based on the previously published method with minor modifications. 13 Briefly, an aliquot of 100 lL plasma sample was spiked with 10 lL of L-2-chlorophenylalanine in water (0.3 mg/mL) and 10 lL of heptadecanoic acid in methanol (1 mg/mL). The mixture was extracted with 300 lL of methanol/chloroform (3:1). After vortexed for 30 sec and stored at 2208C for 10 min, samples were centrifuged at 16,100g for 10 min. An aliquot of the 300 lL supernatant was transferred to a glass sampling vial to vacuum-dry at room temperature. Then, 80-lL of methoxyamine (15 mg/mL in pyridine) was added to the vial and kept at 308C for 90 min, followed by 80 lL BSTFA (1%TMCS) at 708C for 120 min for derivatization to take place. The derivatized samples were then analyzed by an Agilent 6890 N GC coupled with a Pegasus HT TOFMS (Leco Corporation, St Joseph, USA) in the splitless mode. A DB-5 ms capillary column (30 m 3 250 mm I.D., 0.25 mm film thickness; Agilent J&W Scientific, Folsom, CA, USA) was used for separation. The measurements were made with electron impact ionization (70 eV) in the full scan mode (m/z 30-600). Pooled quality control (QC) samples were prepared by mixing aliquots of the study samples such that the pooled samples broadly represent the biological average of the whole sample set. The QC samples for this project were prepared with the test samples and injected after every 10 test samples throughout the analytical run. Solvent blank samples were also added for detection of potential contamination. All samples were prepared in a random order and the lab team was blinded to the case-control status.
Global metabolic profiling of plasma samples by UPLC-QTOFMS 13 Briefly, an aliquot of 100 mL of plasma sample was extracted with a 400 mL mixture of methanol and acetonitrile (5:3, v/v, containing 2-chlorophenylalanine as the internal standard). After being vortexed and centrifuged for 20 min at 16,100 g, the supernatant was used for ultra-performance liquid chromatography quadrupole-time-of-flight mass spectrometry (UPLC-QTOFMS) analysis. A Waters ACQUITY UPLC system equipped with a binary solvent delivery manager and a sample manager (Waters Corporation, Milford, MA) is used with chromatographic separations performed on a 2.1 3 100 mm 1.7 lm ACQUITY BEH C18 chromatography column. Mass spectrometry is performed using a Micromass Q-TOF Premier mass spectrometer equipped with an electrospray interface (Waters Corporation, Milford, MA).
What's new?
Blood metabolites have emerged as novel biomarkers for various cancers but few studies have focused on colorectal cancer. In this prospective study, the authors identified 35 metabolites associated with colorectal cancer risk. The majority of riskassociated metabolites were lipids, especially glycerophospholipids, pointing to a mechanistic connection between colorectal cancer and dysregulation of glycerophospholipid biology.
Metabolomics data analysis
Metabolomics data analysis followed the previous publications. 13 The raw data from UPLC-QTOFMS were analyzed with the MarkerLynx Applications Manager version 4.1 (Waters, Manchester, U.K.). The raw data from GC-TOFMS were processed with ChromaTOF software (v4.22, Leco Co., CA, USA). A total of 131 features were detected by GC-TOFMS and 900 features by UPLC-QTOFMS (205 from positive mode and 695 from negative mode) (Fig. 1) . Compound annotation for GC-TOFMS was performed by comparing the mass fragments with NIST 08 Standard mass spectral database with a similarity of >70% and then verified by available reference standards in the in-house standard library (containing 1200 endogenous metabolites). For UPLC-QTOFMS data, compound annotation was carried out with the aid of available reference standards or the web-based resources such as the Human Metabolome Database (HMDB, www.hmdb.ca). A total of 618 metabolites were identified, of which 167 were annotated by in-house library.
To eliminate analytical variation and minor sensitivity shifts throughout the study, the three data sets (UPLC-QTOFMS POS, NEG and GC-TOFMS) were normalized by their pooled QCs respectively (Eq. 1).
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The normalized data from two platforms were combined and repetitive and ectogenic compounds were removed. Missing values were replaced by minimum of valid data from corresponding compounds.
Statistical analysis
Natural logarithm transformation and standardization according to the mean and standard deviation of all samples were used to normalize the distribution of metabolite data. Levels of a specific metabolite below its detection limit were assigned the lowest detectable value in data analysis. Univariate analyses were performed for each covariate using paired t test (continuous), McNemar's test (binary), or conditional logistic regression model (categorical). For the multiple regression analyses, variables adjusted for included age at interview (years), ever smoking (Yes/No), pack-years smoking, BMI (kg/m 2 ), leisure-time physical activity (Yes/No), alcohol drinking (Yes/No), time interval between last meal and sample collection (hours), intakes of red meat, vegetables and fruits, fiber and fat (all measured by g/d) and total calorie intake (kcal/d), at baseline. We used the BenjaminiHochberg false discovery rate (BH-FDR) <0.05 (based on 618 tests) as the significance level to reduce type I errors due to multiple comparisons. We started the association analyses by estimating ORs associated with per 1 SD increase of logtransformed and standardized metabolites. To assess potential influence of outliers on study results, we also performed categorical data analyses based on tertile distribution of controls for all metabolites that showed a statistically significant association in the analysis using continuous variables.
To understand the intrarelation of metabolites statistically significantly associated with risk of colorectal cancer, we calculated pairwise Spearman's correlation coefficients. We also performed pairwise partial correlation analyses by including all statistically significant metabolites to control effects of other metabolites. To identify metabolites that are independently associated with colorectal cancer risk, we include all metabolites from the same class (lipids, aromatic compounds, organic acids and derivatives and other compounds) that are 
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statistically significantly associated with the risk in a single regression model. Metabolites remained statistically significant in each of these classes were then included in a single model to search for metabolites independently associated with cancer risk. We further estimated the area under the curve (AUC) for separating cancer cases and controls based on levels of these metabolites. In a sensitivity analysis, we excluded subjects who reported a diagnosis of type 2 diabetes and who had cancer diagnosed within first two years. Analyses stratified by time interval between blood collection and cancer diagnosis (<4 years, 4 years) and by cancer site (colon or rectum) were also performed. All statistical analyses were conducted using Stata 14 (StataCorp, College Station, TX) and R (version 3.31).
Results
After excluding samples with poor quality, 245 matched pairs were remained for further analysis. Cases and controls were, in general, well matched on all intended matching covariates. Male cancer cases were 0.3 year younger than their matched controls, and the difference was statistically significant (p < 0.05). Cancer cases had a slightly shorter interval between last meal and sample collection than their controls (cases: 5.0 hr, controls: 6.6 hr, p < 0.001). No statistically significant case-control differences were observed for other characteristics of participants such as body mass index, waist-hip ratio, leisure-time physical activity, alcohol drinking and dietary intakes (Table 1 ). In total, we found 35metabolites that showed a statistically significant association with colorectal cancer at the FDR-p of <0.05 (Table 2) . Similar associations were obtained from univariable models (data not shown). The statistically significantly associated metabolites were mainly glycerophospholipids and other lipids (five associated with increased risk and 14 with decreased risk). The most significant glycerophospholipid and lipid other than glycerophospholipid are PE ( ), respectively. Majority of identified glycerophospholipids were inversely associated with colorectal cancer risk (nine with decreased risk and three with increased risk). In addition, seven aromatic compounds, five organic acids and four other organic compounds were also associated with colorectal cancer risk (10 with increased risk and six with decreased risk). Excluding subjects with prevalent type 2 diabetes did not change the results appreciably (Supporting Information, Table 1 ). Categorical analyses by tertile distributions of these metabolites showed a similar association as those derived from the continuous variable analyses, indicating that the results of these analyses were robust (Supporting Information, Table 2 ).
Many metabolites are correlated (Supporting Information, Fig. 1a) . For example, a close correlation (r > 0.7) was found between N-undecylbenzenesulfonic acid and 2-dodecylbenzenesulfonic acid, isoputreanine and 4-amino-1-piperidinecarboxylic acid and glutamyl-glutamate and isoputreanine. Partial correlation analysis showed a diminished correlation for most pairs ( Supporting Information, Fig. 1b) . After mutual adjustment, nine metabolites were found to be independently associated with colorectal cancer (Table 3) . Risk prediction models built using these metabolites showed an AUC of 0.76.
We conducted further stratified analyses for these independently associated metabolites by time interval between blood collection and cancer diagnosis (Table 4) . Subjects were divided into two groups, <4 years and 4 years, with roughly similar sample size in each group. None of the metabolites associated with colorectal cancer risk exhibited a notable heterogeneity by baseline-diagnosis time interval (p het > 0.05). Excluding subjects who had cancer diagnosed within first two years did not materially change the associations for the identified metabolites (Supporting Information, Table 3 ). The stratified analysis within colorectal cancer by cancer site (colon/rectum, Supporting Information, Table 4 ) suggested stronger associations with rectal cancer risk for PE(p-18:0/18:2) and 4-amino-1-piperidinecarboxylic acid. None of the heterogeneity tests was statistically significant when multiple comparisons were considered.
Discussion
To our knowledge, this is the first prospective metabolomics study conducted in an Asian population to investigate metabolomic biomarkers for colorectal cancer risk. A previous prospective metabolomics study conducted in Caucasians reported an inverse association between leucyl-leucine and colorectal cancer risk for both sexes, although the association was not statistically significant after adjusting for multiple comparisons. 10 Leucyl-leucine is a dipeptide, which is resulted from incomplete breakdown of proteins. However, prior knowledge regarding the link between this metabolite and cancer development has been limited. We cannot evaluate this association as the metabolite was not measured in our study.
Multiple glycerophospholipids, specifically phosphatidylcholines and phosphatidylethanolamines, were inversely associated with risk of colorectal cancer in our study. The associations did not statistically significantly vary by time intervals between blood draw and cancer diagnosis, suggesting that these associations were less likely to be affected by potential bias due to reverse causation. Phosphatidylcholines can be converted from cytidine diphosphocholines, which is originally derived from choline.
14 Prospective studies have reported that a high level of circulating choline is associated with an increased risk of colorectal cancer. 15, 16 Phosphatidylcholines can also be synthesized in the liver via the phosphatidylethanolamine methylation pathways. 14, 17 Phosphatidylethanolamines are derived from cytidine diphosphate ethanolamines, which are downstream derivatives of ethanolamine. Phosphatidylcholines and phosphatidylethanolamines are key components of cell membranes, responsible for maintaining structural integrity. Furthermore, phosphatidylethanolamines are enriched in the mitochondria inner membrane. They regulate key mitochondrial functions such as energy production. 18 Phosphatidylcholines and phosphatidylethanolamines also play critical roles in lipoprotein secretion, lipid droplet formation, de novo lipogenesis and influence the insulin sensitivity of muscles. Therefore, dysregulation of phosphatidylcholines and phosphatidylethanolamines is likely to have a significant impact on lipid profiles, energy balance, and insulin signaling, 18 all of which support key functions in cells. Another important property of phosphatidylcholines, linking it to tumorigenesis, is their potential anti-inflammatory effects. 19 Chronic inflammation-for example, inflammatory bowel disease-is an established risk factor for colorectal cancer. 20 With a few exceptions, most of the phosphatidylcholines and phosphatidylethanolamines were found in our study to be inversely associated with risk of colorectal cancer, consistent with their potential protective roles in the etiology of these cancers either via maintaining cell normal functions or anti-inflammatory functions. Several aromatic compounds were found to be associated with colorectal cancer risk, although most of the observed associations do not appear to be independent from other lipid metabolites. In particular, a positive association was found with coumarin. Coumarin exists in many plants that have a sweet scent. It was initially used as a food additive but later was banned because of its hepatotoxicity in animals. It was also used as a medicine to treat edemas caused by venous and lymphatic drainage disorders. Severe hepatotoxicity adverse events were reported that led to its market withdrawal. 21 Currently, no convincing evidence has been found for potential carcinogenic effect of coumarin in humans. Another risk-associated aromatic compound, 3-aminobenzoic acid, which is used as an intermediate for dyes and pesticides, has been labeled as a toxin or pollutant (from HMDB). We observed increased risk of colorectal cancer in subjects with high levels of picolinic acid. Picolinic acid, a metabolite of tryptophan catabolism, is produced under inflammatory conditions. 22 It may mediate immunosuppression by inhibiting proliferation and metabolic activity of CD41 T cells. 23 On the other hand, picolinic acid has also been reported to have an antitumor effect, with a reduced tumor cell proliferation found in an animal study administered with picolinic acid. 24 More research on this metabolite is needed. 4 The unit of dietary intake is grams/day and presented in mean 6 SD. Further adjusted for age at interview (years) and total calorie intake (kcal) in conditional logistic regression. 5 Time interval between last meal and sample collection (hr).
The observed increased risk of colorectal cancer in subjects with high levels of selenocystine, an organic selenium compound, is in contrast to previous laboratory findings that selenocystine can induce apoptosis of cancer cells via reactive oxygen species generation. 25, 26 Nonetheless, reactive oxygen species itself is a double-edged sword in cancer etiology 27 raising the possibility that long-term exposure to high selenocystine levels may be cancer-promoting, which needs to be further investigated. ORs, 95% CI and p values were derived from multivariable conditional logistic regression. Model included age at interview (years), smoking status (never/ever), pack-years smoking, BMI (kg/m 2 ), regular leisure-time physical activity engagement (Yes/No), ever regularly drank alcohol (Yes/No), time interval between last meal and sample collection (hours), dietary red meat intake (g/d), vegetable and fruit intake (g/d), fiber intake (g/d), fat intake (g/d) and total calorie intake (kcal) at baseline as covariates. The ORs were estimated with respect to 1 SD increase of natural logarithm transformed standardized metabolite levels. 2 Lipids: lipids and lipid-like molecules; aromatic cpd: aromatic compounds; organic acids: organic acids and derivatives; others: other organic compounds.
With a prospective study design, the concern of reverse causation is mitigated, compared to retrospective case-control studies. No statistically significant difference was found for the identified associations when stratified by time interval between blood draw and cancer diagnosis; thus, our findings are less likely to be explained by the presence of occult disease. One limitation of our study is that we can only assess metabolites captured by the metabolomics platform used in this study, and thus other metabolites of interest could not be included in this study. Although we have adjusted for multiple comparisons using the FDR method, we could not rule out entirely that some of the positive association may be due to chance alone, and thus replicating findings from this study would be helpful. The generalizability of our findings remains unclear until similar studies are conducted in other ethnic groups. With an AUC of 0.76, the models including metabolite markers identified in this study showed a moderate discriminatory accuracy in identifying high-risk individuals for colorectal cancer. However, these models need to be validated in future studies as overfitting might be a potential issue. Some of the findings from this study could not be explained satisfactorily given our current limited knowledge on cancer biology. Some of the cancer-associated metabolites identified in this study may be associated with cancer risk via their correlation with other metabolites not evaluated in this study. Therefore, future studies are needed to understand the mechanisms for the associations identified in this study.
In summary, we have identified 35 metabolites associated with colorectal cancer risk in a prospective metabolomics study. Dysregulated glycerophospholipids are most abundantly related to colorectal cancer in this study. Independent studies are warranted to replicate our findings. Table 2 . 2 158 and 87 case-control pairs were included in stratified analysis when the time interval between baseline and cancer diagnosis was <4 years and 4 years, respectively. 3 p het was derived from Cochran's Q test of heterogeneity.
